Home » Topics » BioWorld Science

BioWorld Science
RSS

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Endorecherche claims EM-800 for estrogen-dependent disorders

Oct. 11, 1996

Schering AG's tubulin polymerization inhibitors for cancer

Oct. 11, 1996

Daiichi claims new taxol derivatives

Oct. 11, 1996

Orphan drug status granted for camptothecin derivative

Oct. 11, 1996

Pierre Fabre discloses topoisomerase II inhibitors

Oct. 11, 1996

Nippon Kayaku evaluates novel doxorubicin preparation

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...